Parenterally administerable liposome formulation comprising synthetic lipid
US5270053A · kind A · utility
20Cited by
2References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 9, 1992 |
| Grant date | Dec 14, 1993 |
| Priority date | — |
| Expiry date | Dec 9, 2012 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10T428/2984
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to pharmaceutical compositions in the form of parenterally, especially intravenously, administrable liposome dispersions or dry preparations, especially lyophilisates, that can be used therefor, comprising the zinc-phthalocyanine complex and synthetic, substantially pure phospholipids.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.